BioWorld MedTech

April 30, 2013

Deals roundup: Bayer to acquire Conceptus for $1.1B, via tender offer

Bayer Healthcare (Leverkusen, Germany) said it has signed a merger agreement with Conceptus (Mountain View, California), the developer of the Essure procedure, a non-surgical permanent birth control method, for $1.1 billion. Read More

CVRx obtains FDA nod to start Barostim neo hypertension study

Report from Europe: CircuLite gets final results on Synergy CE mark study

Washington roundup: Defibrillators, spinal fusion, radiotherapy win IPPS draft

Financings roundup: RainDance closes $20M Series E funding round

Court report: AirStrip, mVisum settle suit over physiological data

Agreements/contracts: GenomeDx Biosciences expands Mayo collaboration

Medical Device Daily presents a brand-new webinar

HIT roundup: Johns Hopkins to participate in PathCentral Pathology network

Med-Tech Notes

Product Briefs

People in the News

MDD's Cardio Extra

Today's news in brief

BioWorld

BioWorld briefs for July 10, 2026.

3D rendering of an antibody drug conjugate

‘Target-high but uptake-defective’ state identified in ADC resistance

BioWorld

Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...

Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy

BioWorld

News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...

FENS 2026: Shedding light on the sheddome

BioWorld

At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...

FENS 2026: Next-gen biologics take on brain disease

BioWorld

Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...